Regencell Bioscience Holdings Ltd (RGC) Executive Compensation
Regencell Bioscience Holdings Ltd (RGC) is a publicly traded company on the Nasdaq, categorized under SIC 2833 (Medicinal Chemicals & Botanical Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RGC
CIK: 1829667
Exchange: Nasdaq
SIC 2833: Medicinal Chemicals & Botanical Products
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Marcum Asia CPAs LLP
Auditor SinceSince 6/30/2023 12:00:00 AM
Lead Engagement PartnerYingchien Lan
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 20-F | 2026-10-07 | 2026-06-30 | ANNUAL REPORT | 0001213900-26-107581 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | 4 Filing | 0001213900-26-062409 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-27 | 4 Filing | 0001213900-26-062407 | View SEC Doc Filr Page |
| 6-K | 2026-05-22 | 2026-05-22 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-060337 | View SEC Doc Filr Page |
| 424B5 | 2026-05-19 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-059114 | View SEC Doc Filr Page |
| 6-K | 2026-05-19 | 2026-05-19 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-059056 | View SEC Doc Filr Page |
| 6-K | 2026-05-19 | 2026-05-19 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-058749 | View SEC Doc Filr Page |
| 6-K | 2026-05-08 | 2025-12-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-053892 | View SEC Doc Filr Page |
| 6-K | 2026-04-17 | 2026-04-17 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-045171 | View SEC Doc Filr Page |
| 6-K | 2026-03-30 | 2026-03-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-035953 | View SEC Doc Filr Page |
| 6-K | 2026-03-30 | 2026-03-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-035946 | View SEC Doc Filr Page |
| 424B5 | 2026-03-30 | — | PROSPECTUS SUPPLEMENT | 0001213900-26-035916 | View SEC Doc Filr Page |
| F-3ASR | 2026-03-30 | — | REGISTRATION STATEMENT | 0001213900-26-035884 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-030077 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-030072 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-030067 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-030058 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-030050 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-030041 | View SEC Doc Filr Page |
| 3 | 2026-03-18 | 2026-03-18 | 3 Filing | 0001213900-26-030031 | View SEC Doc Filr Page |
| 6-K | 2026-02-13 | 2026-02-13 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-015922 | View SEC Doc Filr Page |
| 20-F | 2025-10-31 | 2025-06-30 | ANNUAL REPORT | 0001213900-25-104686 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2025-07-11 | — | SCHEDULE 13D/A Filing | 0001213900-25-063278 | View SEC Doc Filr Page |
| 6-K | 2025-06-30 | 2025-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-059294 | View SEC Doc Filr Page |
| 6-K | 2025-06-30 | 2025-06-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-25-059287 | View SEC Doc Filr Page |